Banded Versus Conventional Laparoscopic Roux-en-Y (GABY)

ClinTrio

Status and phase: Unknown; Phase 4

Conditions: Morbid Obesity Requiring Bariatric Surgery

Treatments: Procedure: conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring; Procedure: Conventional laparoscopic Roux-en-Y gastric bypass

Study type: Interventional

Funder types: Other

Identifiers

NCT01015469

EudraCT-No. 2009-016718-26

IT5448081

Details and patient eligibility

About

Banded Versus Conventional Laparoscopic Roux-en-Y Gastric Bypass (GABY).

The aim of this novel study is to evaluate, if an additional restrictive silastic ring can avoid dilation of the gastro-entero anastomosis and adjacent small bowel with consecutive better postoperative weight loss and significantly improved long-term weight maintenance.

The study will not investigate the GaBP-Ring as medical product but the effect of the GaBP-Ring on weight loss in comparison to gastric bypass alone.

Full description

GABY is designed as an international, multi center, open, prospective, randomized study to compare two methods of bariatric surgery: Banded versus conventional laparoscopic Roux-en-Y gastric bypass.

At least 16 international high volume centres of excellence in bariatric surgery and at least 384 patients (24 patients at each center) in total will be included into this study. At least 320 patients must have completed the study after 5 years.

Surgery will be performed according to standardized operating protocol. The group A (control group) will follow the worldwide golden standard of bariatric surgery (gastric bypass). Patients randomised to group B will receive in addition a restrictive silastic ring. The ring is a launched medical product and is registered in the European Community.

Enrollment: 384 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• BMI ≥ 40 kg /m2 to ≤ 50 kg/m2
• Eating habit: sweet eater and volume eater
• Signed informed consent
• Patients with one or more of the following comorbidities: Hypertension, Diabetes mellitus Type 2, Hyperlipidemia, Hyperuricemia, Sleep apnea, Degenerative diseases of: Spine osteochondrosis, hip, knee, feet

Exclusion criteria

• History of obesity surgery
• History of major abdominal surgery with consecutive malabsorption (no resections of the stomach, small and large bowel (exception: appendectomy)
• Patients not eligible to implement silastic ring size 6.5 cm
• History of drug or alcohol abuse
• History of major psychiatric illness conflicting with patient's compliance
• History of recent or chronic steroid medication
• Autoimmune disease
• Inflammatory bowel disease or malabsorptive disease
• Liver cirrhosis (CHILD B + C)
• Active viral or bacterial disease (e.g. HIV, Hepatitis B or C, Tbc etc.)
• Pregnant women or women with childbearing potential without efficient contraception
• History of cancer in the last five years
• Need of long-term anticoagulant medication for any reason
• Any medication with ingredient ASA

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

384 participants in 2 patient groups

Group A

Active Comparator group

Description:

Conventional laparoscopic Roux-en-Y gastric bypass (Golden Standard)

Treatment:

Procedure: Conventional laparoscopic Roux-en-Y gastric bypass

Group B

Experimental group

Description:

Conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring

Treatment:

Procedure: conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring